Source: ClinicalTrials.gov – Retinitis Pigmentosa – Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Condition: Alström SyndromeIntervention: Drug: PBI-4050Sponsor: ProMetic BioSciences Inc.Not yet recruiting – verified June 2017 Source: ClinicalTrials.gov – Retinitis Pigmentosa – Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
Source: Amy’s Adventures – Moving Past Loneliness to Hope Moving Past Loneliness to Hope Witnessing New Love The Wedding takes Place This past March, my family witnessed a milestone event as my brother-in-law moved past the loneliness of my sister’s death and married Deborah Halderman, a woman from Lancaster County, Pennsylvania. …
Source: Foundation Fighting Blindness Blog – Eye on the Cure – Valproic Acid’s Effect Too Small in One-Year Clinical Trial However, researchers identify a potentially powerful endpoint for evaluating emerging therapies in future studies. Results from a clinical trial sponsored by the Foundation Fighting Blindness Clinical Research Institute (FFB-CRI)…
